More widespread use of mammograms, along with the implementation of targeted hormone therapies more than 40 years ago, has ...
Research by UMass Chan Medical School scientists Sharon Cantor, Ph.D., and Jenna M. Whalen, Ph.D., poses a new explanation ...
Oncology, titled "Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention," a research team from Guangzhou ...
A new review published in Genes & Diseases explores the pivotal role of the ubiquitin-proteasome system (UPS) in regulating the tumor microenvironment (TME) and driving cancer progression. The study ...
Research reveals promising advancements of Ce6-GFFY in colorectal cancer treatment. Colorectal cancer (CRC) is a highly malignant disease that readily metastasizes to vital organs. Many strategies ...
Colorectal cancer (CRC) is a highly malignant disease that readily metastasizes to vital organs. Many strategies have been employed for clinical CRC therapy.
Additional presentations from Seer and collaborators will highlight the Proteograph Product Suite’s role in deep proteomic studies to understand tissue biology, uncover biomarkers for cardiometabolic ...
Manipulating the immune system to treat cancer has generated phenomenal responses in some patients, including complete cures, ...
Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. The New York pharma is ending global development and commercialization of ...
Brain Tumor Organoids Accurately Model Patient Response to CAR T Cell Therapy Dec. 9 ... could have significant implications ... Tumor Suppressor Protein Par-4 Triggers Unique Cell Death Pathway ...
therapies. But while health care providers can now successfully develop drugs that use dsRNA to accurately target and silence disease-causing genes, a major challenge remains: getting these ...
Over 30 gene therapies have received regulatory approval. However, there is still considerable room for the industry to improve the safety, efficacy, and affordability of these life-saving treatments.